Materiality pending
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
- OPKO Health reported a loss of 12 cents per share, wider than last year's 2 cents. - Revenues decreased to $173.7 million, missing estimates, especially from intellectual property transfer. - Pharmaceuticals revenue declined by 5.7% due to international sales decrease and currency fluctuations. - Gross profit declined 57.7% primarily due to the absence of upfront payments. - OPKO Health expects second-quarter revenues between $180 million and $185 million. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Earnings
- OPKO Health reported a loss of 12 cents per share, wider than last year's 2 cents.
- Revenues decreased to $173.7 million, missing estimates, especially from intellectual property transfer.
- Pharmaceuticals revenue declined by 5.7% due to international sales decrease and currency fluctuations.
- Gross profit declined 57.7% primarily due to the absence of upfront payments.
- OPKO Health expects second-quarter revenues between $180 million and $185 million.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.